Literature DB >> 22499091

Agreement between clinical screening procedures for neuropathy in the feet.

Yi Wang1, Jaclyn M Goodrich, Robert Werner, Brenda Gillespie, Niladri Basu, Alfred Franzblau.   

Abstract

INTRODUCTION: The correlation between monofilament testing, symptom surveys, and electrodiagnostic studies for the diagnosis of axonal polyneuropathy has not been well studied. This investigation was done to assess the agreement between these procedures in a non-random sample of volunteers.
METHODS: The procedures evaluated included electrodiagnostic tests of the sural nerve, monofilament testing of the great toe, a symptom survey, and a body diagram. Kappa coefficients and sensitivity and specificity, using nerve conduction as a "gold standard," were used to determine the agreement between various combinations of procedures.
RESULTS: Poor agreement (kappa values -0.12-0.44) and sensitivity (sensitivity <30%) were found for all combinations of symptoms and monofilament results in comparison with sural peak latency and amplitude.
CONCLUSIONS: Overall, the results demonstrated a low discriminatory power for the screening procedures for identifying persons with impaired sural nerve function. The results highlight the need for further development and evaluation of screening methods for distal neuropathy in population-based studies.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22499091      PMCID: PMC3335757          DOI: 10.1002/mus.23238

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Agreement between symptom surveys, physical examination procedures and electrodiagnostic findings for the carpal tunnel syndrome.

Authors:  M M Homan; A Franzblau; R A Werner; J W Albers; T J Armstrong; M B Bromberg
Journal:  Scand J Work Environ Health       Date:  1999-04       Impact factor: 5.024

2.  Reliability of nerve conduction studies among active workers.

Authors:  D F Salerno; R A Werner; J W Albers; M P Becker; T J Armstrong; A Franzblau
Journal:  Muscle Nerve       Date:  1999-10       Impact factor: 3.217

3.  Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement.

Authors: 
Journal:  Muscle Nerve       Date:  2002-06       Impact factor: 3.217

4.  Effect of aging on sensory nerve conduction study parameters.

Authors:  Henry C Tong; Robert A Werner; Alfred Franzblau
Journal:  Muscle Nerve       Date:  2004-05       Impact factor: 3.217

Review 5.  Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

Authors:  J D England; G S Gronseth; G Franklin; R G Miller; A K Asbury; G T Carter; J A Cohen; M A Fisher; J F Howard; L J Kinsella; N Latov; R A Lewis; P A Low; A J Sumner
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

6.  Underdiagnosis of peripheral neuropathy in type 2 diabetes.

Authors:  William H Herman; Laurence Kennedy
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

7.  Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial.

Authors:  Shawn J Bird; Mark J Brown; Cathie Spino; Sharon Watling; Howard L Foyt
Journal:  Muscle Nerve       Date:  2006-08       Impact factor: 3.217

Review 8.  The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy.

Authors:  Yuzhe Feng; Felix J Schlösser; Bauer E Sumpio
Journal:  J Vasc Surg       Date:  2009-07-30       Impact factor: 4.268

9.  Principles and pitfalls of nerve conduction studies.

Authors:  J Kimura
Journal:  Ann Neurol       Date:  1984-10       Impact factor: 10.422

10.  Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes.

Authors:  John C Kincaid; Karen L Price; Maria C Jimenez; Vladimir Skljarevski
Journal:  Muscle Nerve       Date:  2007-12       Impact factor: 3.217

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.